Statistics for Lexaria Bioscience Corp. (id:6130 LEXX)
Valuation metrics
Market cap
40.84M
Enterprise value
24.94M
Trailing P/E (ttm)
-2.06
Forward P/E
-5.79
PEG ratio
-5.79
Price/Sales (ttm)
99.36
Price/Book (mrq)
3.53
Enterprise Value/Revenue
60.67
Enterprise Value/EBITDA
-5.50
Overview
Shares outstanding
17.45M
Float
13.23M
Shares short
342.37K
% Held by insiders
5.00%
% Held by institutions
5.00%
Average volume (10 days)
222.87K
Average volume (90 days)
Price summary
52-Week low
1.20
52-Week high
6.85
52-Week change
42.08%
Beta
1.06
50-Day moving average
2.49
200-Day moving average
3.03
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
January 12, 2021
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
August 31, 2023
Most recent quarter (mrq)
August 31, 2024
Profitability
Profit margin
98.96%
Operating margin
-2,074.90%
Operational effectiveness
Return on assets
-38.21%
Return on equity
-70.66%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
459.46K
EBITDA
-4,533,468.00
Net income to common (ttm)
-4,849,874.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
8.51M
Total cash per share (mrq)
3.00
Total debt (mrq)
142.59K
Total Debt/Equity (mrq)
1.46
Current ratio (mrq)
5.83K%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-4,689,024.00
Levered free cash flow (LFCF)
-3,212,450.00